Some limitations but real data, from multi center, various providers across different practices
How many discontinue #ActiveSurveillance for low-grade #ProstateCancer?View quoted post on X
In a population-based study from Ontario 🇨🇦 the answer is about 50% at 5 years and about two thirds at 10 years
Cancer-specific survival was 98% at 10 years
auajournals.org/doi/epdf/10.10…
#EBM @CanUrolAssoc